Search

Traviss C. Mcintosh Iii

Examiner (ID: 1990, Phone: (571)272-0657 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1621, 1693, 1623, 1673
Total Applications
1933
Issued Applications
1263
Pending Applications
174
Abandoned Applications
514

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18886372 [patent_doc_number] => 11865128 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-09 [patent_title] => Aminoglycosides and uses thereof in treating genetic disorders [patent_app_type] => utility [patent_app_number] => 17/226050 [patent_app_country] => US [patent_app_date] => 2021-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 59 [patent_no_of_words] => 30943 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17226050 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/226050
Aminoglycosides and uses thereof in treating genetic disorders Apr 7, 2021 Issued
Array ( [id] => 17726561 [patent_doc_number] => 11382926 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-12 [patent_title] => Methods for treating [patent_app_type] => utility [patent_app_number] => 17/222066 [patent_app_country] => US [patent_app_date] => 2021-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 44751 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17222066 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/222066
Methods for treating Apr 4, 2021 Issued
Array ( [id] => 19157680 [patent_doc_number] => 20240150387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-09 [patent_title] => GLUCOCEREBROSIDE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/279150 [patent_app_country] => US [patent_app_date] => 2021-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8910 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279150 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/279150
GLUCOCEREBROSIDE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF Apr 1, 2021 Pending
Array ( [id] => 16977599 [patent_doc_number] => 20210221836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS [patent_app_type] => utility [patent_app_number] => 17/221201 [patent_app_country] => US [patent_app_date] => 2021-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14449 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221201 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/221201
IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS Apr 1, 2021 Abandoned
Array ( [id] => 20357339 [patent_doc_number] => 12473322 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-18 [patent_title] => Polymeric amphoteric surfactant compound [patent_app_type] => utility [patent_app_number] => 17/915843 [patent_app_country] => US [patent_app_date] => 2021-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 0 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915843 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/915843
Polymeric amphoteric surfactant compound Mar 30, 2021 Issued
Array ( [id] => 20453032 [patent_doc_number] => 12516082 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-06 [patent_title] => Metal-carbohydrate complex [patent_app_type] => utility [patent_app_number] => 17/915822 [patent_app_country] => US [patent_app_date] => 2021-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 1857 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915822 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/915822
Metal-carbohydrate complex Mar 30, 2021 Issued
Array ( [id] => 18685154 [patent_doc_number] => 11780871 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-10-10 [patent_title] => COVID-19 treatment and methods [patent_app_type] => utility [patent_app_number] => 17/215839 [patent_app_country] => US [patent_app_date] => 2021-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3848 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17215839 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/215839
COVID-19 treatment and methods Mar 28, 2021 Issued
Array ( [id] => 18399310 [patent_doc_number] => 11661436 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-30 [patent_title] => Method for preparing 3'-o-amino-2'-deoxyribonucleoside-5'-triphosphates [patent_app_type] => utility [patent_app_number] => 17/214245 [patent_app_country] => US [patent_app_date] => 2021-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 1733 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17214245 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/214245
Method for preparing 3'-o-amino-2'-deoxyribonucleoside-5'-triphosphates Mar 25, 2021 Issued
Array ( [id] => 18337761 [patent_doc_number] => 20230129710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => Methods and Reagents for Synthesizing Nucleosides and Analogues Thereof [patent_app_type] => utility [patent_app_number] => 17/913920 [patent_app_country] => US [patent_app_date] => 2021-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28367 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913920 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/913920
Methods and Reagents for Synthesizing Nucleosides and Analogues Thereof Mar 24, 2021 Pending
Array ( [id] => 19447295 [patent_doc_number] => 20240307425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => PHARMACEUTICAL COMPOSITION FOR TREATING SEPSIS AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/272466 [patent_app_country] => US [patent_app_date] => 2021-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14637 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18272466 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/272466
PHARMACEUTICAL COMPOSITION FOR TREATING SEPSIS AND USE THEREOF Mar 22, 2021 Pending
Array ( [id] => 17110055 [patent_doc_number] => 20210290652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-23 [patent_title] => SEQUENTIAL TREATMENT OF CANCERS USING 6-THIO-dG, CHECKPOINT INHIBITORS AND RADIATION THERAPY [patent_app_type] => utility [patent_app_number] => 17/200539 [patent_app_country] => US [patent_app_date] => 2021-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21362 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17200539 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/200539
Sequential treatment of cancers using 6-thio-dG, checkpoint inhibitors and radiation therapy Mar 11, 2021 Issued
Array ( [id] => 18348066 [patent_doc_number] => 20230136177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => IMMUNOMODULATING O-HET/ARYL AZALIDES [patent_app_type] => utility [patent_app_number] => 17/801340 [patent_app_country] => US [patent_app_date] => 2021-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60498 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 759 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801340 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/801340
Immunomodulating o-het/aryl azalides Mar 10, 2021 Issued
Array ( [id] => 18413128 [patent_doc_number] => 11667661 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-06 [patent_title] => Benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent comprising the same [patent_app_type] => utility [patent_app_number] => 17/195425 [patent_app_country] => US [patent_app_date] => 2021-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 5899 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17195425 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/195425
Benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent comprising the same Mar 7, 2021 Issued
Array ( [id] => 17604019 [patent_doc_number] => 11332490 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-05-17 [patent_title] => Compounds and methods for treating osteoarthritis [patent_app_type] => utility [patent_app_number] => 17/182156 [patent_app_country] => US [patent_app_date] => 2021-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 14882 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182156 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/182156
Compounds and methods for treating osteoarthritis Feb 21, 2021 Issued
Array ( [id] => 18610846 [patent_doc_number] => 20230277576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => A METHOD FOR PREVENTING OR TREATING A CORNAVIRUS INFECTIOUS DISEASE [patent_app_type] => utility [patent_app_number] => 17/905142 [patent_app_country] => US [patent_app_date] => 2021-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2631 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905142 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/905142
A METHOD FOR PREVENTING OR TREATING A CORNAVIRUS INFECTIOUS DISEASE Feb 19, 2021 Pending
Array ( [id] => 18326513 [patent_doc_number] => 20230124641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-20 [patent_title] => CROSS-LINKED NUCLEOSIDE AND NUCLEOTIDE USING SAME [patent_app_type] => utility [patent_app_number] => 17/800339 [patent_app_country] => US [patent_app_date] => 2021-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21646 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 229 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800339 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/800339
Cross-linked nucleoside and nucleotide using same Feb 16, 2021 Issued
Array ( [id] => 18320940 [patent_doc_number] => 20230119068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-20 [patent_title] => METHODS FOR RAPID SYNTHESIS OF PYRANOANTHOCYANINS [patent_app_type] => utility [patent_app_number] => 17/799393 [patent_app_country] => US [patent_app_date] => 2021-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14207 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17799393 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/799393
METHODS FOR RAPID SYNTHESIS OF PYRANOANTHOCYANINS Feb 15, 2021 Pending
Array ( [id] => 17213079 [patent_doc_number] => 20210346415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/176450 [patent_app_country] => US [patent_app_date] => 2021-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23754 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176450 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/176450
PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF Feb 15, 2021 Abandoned
Array ( [id] => 18748552 [patent_doc_number] => 11807851 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-11-07 [patent_title] => Modified polynucleotides and uses thereof [patent_app_type] => utility [patent_app_number] => 17/176617 [patent_app_country] => US [patent_app_date] => 2021-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 46067 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 605 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176617 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/176617
Modified polynucleotides and uses thereof Feb 15, 2021 Issued
Array ( [id] => 17256770 [patent_doc_number] => 20210369755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-02 [patent_title] => 4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication [patent_app_type] => utility [patent_app_number] => 17/174726 [patent_app_country] => US [patent_app_date] => 2021-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10449 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17174726 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/174726
4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication Feb 11, 2021 Abandoned
Menu